Medicare Procedure and Patient Information
Conditions of Medicare patients treated by Dr. Mathew R. Meeneghan, MD in 2014
The most common conditions of Medicare patients that Dr. Mathew R. Meeneghan, MD treated during 2014 were hypertension.
73 | |
(No ratings)
Dr. Mathew R. Meeneghan, MD is a medical oncologist in Bastrop, TX specializing in medical oncology, adult oncology and adult hematology. He graduated from University of Virginia School of Medicine. Dr. Mathew R. Meeneghan, MD is affiliated with CHRISTUS Health, Ascension, St. David's HealthCare, Texas Oncology, Dell Seton Medical Center, AdventHealth, The University of Texas (UT) System, Ascension Seton Hays, Ascension Seton Medical Center Austin, St. David's South Austin Medical Center, Ascension Seton Williamson, Ascension Seton Northwest and Ascension Seton Smithville.
3107 Highway 71 East
Bastrop, TX 78602
3107 State Highway 71
Bastrop, TX 78602
4101 James Casey Boulevard Suite 100
Austin, TX 78745
901 W. 38th Street Suite 200
Austin, TX 78705
The most common conditions of Medicare patients that Dr. Mathew R. Meeneghan, MD treated during 2014 were hypertension.
Hypertension | 73 |
---|---|
High Cholesterol | 0 |
Stroke | 0 |
Ischemic Heart Disease | 0 |
Depression | 0 |
Chronic Kidney Disease | 0 |
Asthma | 0 |
Osteoperosis | 0 |
Atrial Fibrilation | 0 |
Heart Failure | 0 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 0 |
Dementia | 0 |
Cancer | 0 |
The top procedures that Dr. Mathew R. Meeneghan, MD treated as a medical oncologist in Bastrop, TX during 2015 were lab tests, blood draw, and .
Volume of procedures performed by Dr. Mathew R. Meeneghan, MD for Medicare patients.
blood draw | 103 |
---|---|
doctor visit | 156 |
lab tests | 152 |
Information about Medicare patients treated by Dr. Mathew R. Meeneghan, MD.
Male | 72 |
---|---|
Female | 110 |
Non-Hispanic White | 156 |
---|---|
Black | 0 |
Hispanic | 0 |
Asian | 0 |
Other | 0 |
Native American | 0 |
From 65 to 74 | 92 |
---|---|
From 75 to 84 | 44 |
85 and over | 0 |
Less than 65 | 0 |
The most common conditions of Medicare patients that Dr. Mathew R. Meeneghan, MD treated during 2015 were hypertension, high cholesterol, ischemic heart disease and chronic kidney disease.
Hypertension | 69 |
---|---|
High Cholesterol | 57 |
Stroke | 0 |
Ischemic Heart Disease | 40 |
Depression | 30 |
Chronic Kidney Disease | 36 |
Asthma | 21 |
Osteoperosis | 0 |
Atrial Fibrilation | 14 |
Heart Failure | 25 |
Chronic Obstructive Pulmonary Disease | 19 |
Diabetes | 34 |
Dementia | 18 |
Cancer | 33 |
The top procedures that Dr. Mathew R. Meeneghan, MD treated as a medical oncologist in Bastrop, TX during 2016 were lab tests, blood draw, minimally invasive procedures and inpatient care.
Volume of procedures performed by Dr. Mathew R. Meeneghan, MD for Medicare patients.
aspiration | 13 |
---|---|
biological response modifier (BRM) therapy | 199 |
blood draw | 696 |
bone marrow tests | 29 |
chemotherapy | 199 |
diagnostic procedures | 29 |
doctor visit | 807 |
hospital care | 255 |
inpatient care | 255 |
lab tests | 1606 |
minimally invasive procedures | 326 |
port flush | 61 |
Information about Medicare patients treated by Dr. Mathew R. Meeneghan, MD.
Male | 220 |
---|---|
Female | 202 |
Non-Hispanic White | 344 |
---|---|
Black | 0 |
Hispanic | 43 |
Asian | 0 |
Other | 0 |
Native American | 0 |
From 65 to 74 | 184 |
---|---|
From 75 to 84 | 126 |
85 and over | 63 |
Less than 65 | 49 |
The most common conditions of Medicare patients that Dr. Mathew R. Meeneghan, MD treated during 2016 were hypertension, high cholesterol, ischemic heart disease and chronic kidney disease.
Hypertension | 72 |
---|---|
High Cholesterol | 56 |
Stroke | 7 |
Ischemic Heart Disease | 46 |
Depression | 28 |
Chronic Kidney Disease | 44 |
Asthma | 25 |
Osteoperosis | 8 |
Atrial Fibrilation | 17 |
Heart Failure | 28 |
Chronic Obstructive Pulmonary Disease | 22 |
Diabetes | 34 |
Dementia | 14 |
Cancer | 37 |
The top procedures that Dr. Mathew R. Meeneghan, MD treated as a medical oncologist in Bastrop, TX during 2017 were lab tests, blood draw, minimally invasive procedures and inpatient care.
Volume of procedures performed by Dr. Mathew R. Meeneghan, MD for Medicare patients.
aspiration | 18 |
---|---|
biological response modifier (BRM) therapy | 234 |
blood draw | 882 |
bone marrow tests | 36 |
chemotherapy | 234 |
diagnostic procedures | 36 |
doctor visit | 1220 |
hormone therapy | 11 |
hospital care | 313 |
inpatient care | 313 |
lab tests | 3290 |
minimally invasive procedures | 400 |
port flush | 98 |
thyroid function tests | 33 |
Information about Medicare patients treated by Dr. Mathew R. Meeneghan, MD.
Male | 280 |
---|---|
Female | 308 |
Non-Hispanic White | 474 |
---|---|
Black | 43 |
Hispanic | 57 |
Asian | 0 |
Other | 0 |
Native American | 0 |
From 65 to 74 | 258 |
---|---|
From 75 to 84 | 190 |
85 and over | 79 |
Less than 65 | 61 |
The most common conditions of Medicare patients that Dr. Mathew R. Meeneghan, MD treated during 2017 were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.
Hypertension | 73 |
---|---|
High Cholesterol | 55 |
Stroke | 9 |
Ischemic Heart Disease | 46 |
Depression | 31 |
Chronic Kidney Disease | 46 |
Asthma | 9 |
Osteoperosis | 9 |
Atrial Fibrilation | 18 |
Heart Failure | 27 |
Chronic Obstructive Pulmonary Disease | 22 |
Diabetes | 35 |
Dementia | 16 |
Cancer | 37 |
The top procedures that Dr. Mathew R. Meeneghan, MD treated as a medical oncologist in Bastrop, TX during 2018 were lab tests, blood draw, minimally invasive procedures and chemotherapy.
Volume of procedures performed by Dr. Mathew R. Meeneghan, MD for Medicare patients.
abdominal imaging | 21 |
---|---|
biological response modifier (BRM) therapy | 290 |
blood draw | 1060 |
chemotherapy | 290 |
CT scan | 46 |
doctor visit | 1377 |
hormone therapy | 42 |
hospital care | 283 |
inpatient care | 283 |
lab tests | 4213 |
minimally invasive procedures | 414 |
pelvic imaging | 21 |
port flush | 99 |
thoracic (chest) imaging | 25 |
thyroid function tests | 55 |
Information about Medicare patients treated by Dr. Mathew R. Meeneghan, MD.
Male | 313 |
---|---|
Female | 361 |
Non-Hispanic White | 532 |
---|---|
Black | 42 |
Hispanic | 79 |
Asian | 0 |
Other | 0 |
Native American | 0 |
From 65 to 74 | 313 |
---|---|
From 75 to 84 | 217 |
85 and over | 85 |
Less than 65 | 59 |
The most common conditions of Medicare patients that Dr. Mathew R. Meeneghan, MD treated during 2018 were hypertension, high cholesterol, cancer and chronic kidney disease.
Hypertension | 72 |
---|---|
High Cholesterol | 55 |
Stroke | 7 |
Ischemic Heart Disease | 42 |
Depression | 25 |
Chronic Kidney Disease | 43 |
Asthma | 8 |
Osteoperosis | 10 |
Atrial Fibrilation | 16 |
Heart Failure | 25 |
Chronic Obstructive Pulmonary Disease | 20 |
Diabetes | 33 |
Dementia | 16 |
Cancer | 43 |
The top procedures that Dr. Mathew R. Meeneghan, MD treated as a medical oncologist in Bastrop, TX during 2019 were lab tests, blood draw, minimally invasive procedures and chemotherapy.
Volume of procedures performed by Dr. Mathew R. Meeneghan, MD for Medicare patients.
biological response modifier (BRM) therapy | 368 |
---|---|
blood draw | 1388 |
chemotherapy | 368 |
CT scan | 10 |
doctor visit | 1340 |
hormone therapy | 39 |
hospital care | 285 |
inpatient care | 285 |
lab tests | 5170 |
minimally invasive procedures | 566 |
port flush | 103 |
thoracic (chest) imaging | 11 |
thyroid function tests | 41 |
Information about Medicare patients treated by Dr. Mathew R. Meeneghan, MD.
Male | 351 |
---|---|
Female | 399 |
Non-Hispanic White | 607 |
---|---|
Black | 47 |
Hispanic | 76 |
Asian | 0 |
Other | 0 |
Native American | 0 |
From 65 to 74 | 340 |
---|---|
From 75 to 84 | 252 |
85 and over | 95 |
Less than 65 | 63 |
The most common conditions of Medicare patients that Dr. Mathew R. Meeneghan, MD treated during 2019 were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.
Hypertension | 72 |
---|---|
High Cholesterol | 58 |
Stroke | 6 |
Ischemic Heart Disease | 43 |
Depression | 29 |
Chronic Kidney Disease | 44 |
Asthma | 8 |
Osteoperosis | 10 |
Atrial Fibrilation | 17 |
Heart Failure | 27 |
Chronic Obstructive Pulmonary Disease | 20 |
Diabetes | 33 |
Dementia | 17 |
Cancer | 41 |
The top procedures that Dr. Mathew R. Meeneghan, MD treated as a medical oncologist in Bastrop, TX during 2020 were lab tests, blood draw, minimally invasive procedures and chemotherapy.
Volume of procedures performed by Dr. Mathew R. Meeneghan, MD for Medicare patients.
biological response modifier (BRM) therapy | 373 |
---|---|
blood draw | 1395 |
chemotherapy | 373 |
doctor visit | 1375 |
hormone therapy | 46 |
hospital care | 308 |
inpatient care | 308 |
lab tests | 5503 |
minimally invasive procedures | 553 |
port flush | 61 |
thyroid function tests | 29 |
Information about Medicare patients treated by Dr. Mathew R. Meeneghan, MD.
Male | 327 |
---|---|
Female | 406 |
Non-Hispanic White | 582 |
---|---|
Black | 47 |
Hispanic | 86 |
Asian | 0 |
Other | 0 |
Native American | 0 |
From 65 to 74 | 356 |
---|---|
From 75 to 84 | 244 |
85 and over | 89 |
Less than 65 | 44 |
The most common conditions of Medicare patients that Dr. Mathew R. Meeneghan, MD treated during 2020 were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.
Hypertension | 70 |
---|---|
High Cholesterol | 58 |
Stroke | 7 |
Ischemic Heart Disease | 44 |
Depression | 29 |
Chronic Kidney Disease | 44 |
Asthma | 7 |
Osteoperosis | 11 |
Atrial Fibrilation | 16 |
Heart Failure | 26 |
Chronic Obstructive Pulmonary Disease | 15 |
Diabetes | 32 |
Dementia | 17 |
Cancer | 42 |
The top procedures that Dr. Mathew R. Meeneghan, MD treated as a medical oncologist in Bastrop, TX during 2021 were lab tests, blood draw, minimally invasive procedures and chemotherapy.
Volume of procedures performed by Dr. Mathew R. Meeneghan, MD for Medicare patients.
biological response modifier (BRM) therapy | 675 |
---|---|
blood draw | 2833 |
chemotherapy | 675 |
doctor visit | 2233 |
hormone therapy | 65 |
hospital care | 581 |
inpatient care | 581 |
lab tests | 9808 |
minimally invasive procedures | 962 |
port flush | 51 |
thyroid function tests | 77 |
Volume of procedures performed by Dr. Mathew R. Meeneghan, MD for Medicare patients.
The highest averages for the top procedures that Dr. Mathew R. Meeneghan, MD treated as a medical oncologist in Bastrop, TX were lab tests, blood draw, minimally invasive procedures and chemotherapy.
abdominal imaging | 21 |
---|---|
aspiration | 15 |
biological response modifier (BRM) therapy | 356 |
blood draw | 1194 |
bone marrow tests | 32 |
chemotherapy | 356 |
CT scan | 28 |
diagnostic procedures | 32 |
doctor visit | 1216 |
hormone therapy | 40 |
hospital care | 337 |
inpatient care | 337 |
lab tests | 4256 |
minimally invasive procedures | 536 |
pelvic imaging | 21 |
thoracic (chest) imaging | 18 |
thyroid function tests | 47 |
Information about Medicare patients treated by Dr. Mathew R. Meeneghan, MD.
Female | 178 |
---|---|
Male | 156 |
Black / African American | 17 |
---|---|
Asian / Pacific Islander | 0 |
Non-Hispanic White | 269 |
Native American / Alaskan Native | 0 |
Hispanic | 34 |
Other | 0 |
85 and over | 41 |
---|---|
75 to 84 | 107 |
Less than 65 | 27 |
65 to 74 | 154 |
The highest averages of the most common conditions of Medicare patients that Dr. Mathew R. Meeneghan, MD treated were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.
Hypertension | 50 |
---|---|
High Cholesterol | 33 |
Stroke | 3 |
Ischemic Heart Disease | 26 |
Depression | 17 |
Chronic Kidney Disease | 25 |
Asthma | 7 |
Osteoporosis | 4 |
Heart Failure | 15 |
Chronic Obstructive Pulmonary Disease | 11 |
Diabetes | 20 |
Atrial Fibrillation | 9 |
Cancer | 23 |
Dementia | 9 |
Dr. Mathew R. Meeneghan, MD graduated from University of Virginia School of Medicine. He completed residency at Vanderbilt University Medical Center. He is certified by the The American Board of Internal Medicine - Hematology The American Board of Internal Medicine - Internal Medicine The American Board of Internal Medicine - Medical Oncology and has a state license in North Carolina.
Medical School: University of Virginia School of Medicine
Residency: Vanderbilt University Medical Center
Board Certification: The American Board of Internal Medicine - Hematology The American Board of Internal Medicine - Internal Medicine The American Board of Internal Medicine - Medical Oncology
Licensed In: North Carolina
Dr. Mathew R. Meeneghan, MD is associated with these hospitals and organizations:
Dr. Mathew R. Meeneghan, MD does not have any reviews yet, be the first to leave a review of Dr. Mathew R. Meeneghan, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Mathew R. Meeneghan, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
Janssen Biotech, Inc. |
$505
Erleada $352 |
TECVAYLI $58 |
DARZALEX $53 |
IMBRUVICA $43 |
||
---|---|---|---|---|---|---|
Novartis Pharmaceuticals Corporation |
$350
TASIGNA $127 |
PROMACTA $67 |
Fabhalta $32 |
PIQRAY $25 |
ADAKVEO $23 |
Other $76 |
Seagen Inc. |
$271
PADCEV $145 |
ADCETRIS $77 |
TUKYSA $49 |
|||
Genentech USA, Inc. |
$247
Venclexta $212 |
Phesgo $25 |
Cotellic $10 |
|||
Merck Sharp & Dohme LLC |
$216
KEYTRUDA $143 |
LYNPARZA $73 |
||||
Other |
$1,936
ULTOMIRIS $175 |
NINLARO $131 |
IMBRUVICA $123 |
VYXEOS $122 |
JAKAFI $103 |
Other $1,283 |
Food and Beverage | $3,287 |
---|---|
Honoraria | $150 |
Education | $88 |
Dr. Mathew Meeneghan, who practices in Austin, TX and Bastrop, TX, is a medical specialist in adult hematology, adult oncology, and medical oncology. Dr. Meeneghan's areas of expertise include the following: cancer surgery, red blood cell disorders, and stereotactic body radiation therapy (SBRT). He is professionally affiliated with AdventHealth, Dell Seton Medical Center, and CHRISTUS Health. AdventHealth reports that he is accepting new patients at his office in Austin, TX. He graduated from the University of Virginia School of Medicine and then he performed his residency at Vanderbilt University Medical Center.